Hostname: page-component-78c5997874-dh8gc Total loading time: 0 Render date: 2024-11-19T08:58:17.997Z Has data issue: false hasContentIssue false
  • English
  • Français

“Ritalin” and Chlorpromazine in Chronic Schizophrenia: a Controlled Clinical Trial

Published online by Cambridge University Press:  08 February 2018

Barbara J. Salisbury  and
E. H. Hare
Barbara J. Salisbury
Affiliation:
Consultant Psychiatrist Warlingham Park Hospital, Surrey
E. H. Hare
Affiliation:
Consultant Psychiatrist Warlingham Park Hospital, Surrey
Get access Rights & Permissions [Opens in a new window]

Extract

Ritalin (methylphenidate) is a drug which was developed by the firm of Ciba Limited. It resembles amphetamine in its central stimulant and sympathomimetic action but has quite a different chemical structure. Its general properties have been described by Meier et al. (1954) and by Drassdo and Schmidt (1954 a, b). Geller (1955) and Stier (1955) used Ritalin in the treatment of depressive states associated with apathy, while Ferguson (1955) found it of value in countering the depressive effects of reserpine therapy. Ferguson also notes that Ritalin seemed to have a beneficial action in cases of chronic schizophrenia and considered that his findings warranted a clinical trial.

Type
Original Articles
Information
Journal of Mental Science , Volume 103 , Issue 433 , October 1957 , pp. 830 - 834
Copyright
Copyright © Royal College of Psychiatrists, 1957 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Azima, H., and Ogle, W., Canad. med. Ass. J., 1954, 71, 116.Google Scholar
Carey, B., Weber, M., and Smith, J. A., Amer. J. Psychiat., 1956, 113, 546.Google Scholar
Clark, L. D., Ellsworth, R. B., Barrett, W. W., Thurman, A. C., and Holland, W., Dis. Nerv. Syst., 1956, 17, 317.Google Scholar
Drassdo, A., and Schmidt, M., Med. Monatschr., 1954a, 8, 306.Google Scholar
Idem , ibid., 1954b, 8, 393.Google Scholar
Feldman, P. E., Lacy, B. S., Walker, A. E., and Garrez, N. J., Bull. Menninger Clin., 1956, 20, 25.Google Scholar
Ferguson, J. T., Ann. N.Y. Acad. Sci., 1955, 61, 101.Google Scholar
Fullerton, A. G., J. Ment. Sci., 1956, 102, 801.Google Scholar
Geller, W., Medizinische, 1955, 16, 606.Google Scholar
Greenblatt, M., and Solomon, H. C., Frontal Lobes and Schizophrenia, 1953. New York, p. 78.Google Scholar
Meier, R., Gross, F., and Tripod, J., Klin. Wschr., 1954, 32, 445.Google Scholar
Mitchell, P. H., J. Ment. Sci., 1956, 102, 151.Google Scholar
Newbold, H. L., and Steed, W. D., J. Nerv. Ment. Dis., 1956, 123, 270.Google Scholar
Rockmore, L., Shatin, L., and Funk, I. C., Psychiat. Quart., 1956, 30, 189.CrossRefGoogle Scholar
Shepherd, M., and Watt, D. C., J. Neurol. Neurosurg. Psychiat., 1956, 19, 232.Google Scholar
Stier, C., Therap. I. Gegenw., 1955, 94, 92.Google Scholar
Vaughan, G. F., Leiberman, D. M., and Cook, L. C., Lancet, 1955, i, 1083.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.